Co-Chairs, Elena Elez, MD, PhD, and Yelena Y. Janjigian, MD, discuss HER2+ gastrointestinal cancers in this CME/MOC activity titled “Realizing Improved Outcomes in HER2-Positive Gastrointestinal Cancers: New Evidence and Practical Guidance With Targeted Agents.” For the full presentation, downloadable Practice Aids, and complete CME/MOC information, and to apply for credit, please visit us at https://bit.ly/3M1hDvv. CME/MOC credit will be available until July 31, 2023.